-transparent.png){kind=logo}
A total of 25 plasma and saliva samples were obtained from three hospital inpatients upon intravenous short-time infusion of cyclophosphamide; total doses infused ranged from 5.3 to 13.3 mg/kg. Despite interindividual variations, a correlation was found for plasma-to-saliva ratio of 1.61 +/- 0.53 (S.D.). Our Saliva-to-plasma ratio of 0.62 is in agreement with a recently reported ratio of 0.77. The ratio stayed constant throughout the observation period (0.5 to 8.4 hours), indicating that the noninvasive method of saliva sampling seems to be a useful approach in cyclophosphamide drug concentration monitoring in patients.
Related Publications
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
November 1979,
British journal of clinical pharmacology,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
January 1982,
Cancer chemotherapy and pharmacology,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
January 1981,
British journal of clinical pharmacology,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
November 1971,
British journal of pharmacology,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
January 1973,
Clinical pharmacology and therapeutics,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
September 1972,
The Journal of clinical endocrinology and metabolism,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
October 1938,
The Biochemical journal,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
May 1973,
The Journal of pharmacology and experimental therapeutics,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
March 1971,
Transplantation proceedings,
W A Ritschel, and
G Bykadi, and
E J Norman, and
R J Cluxton, and
D Denton
July 1965,
Journal of pharmaceutical sciences,
